You are here

Article Text

Article menu
Download PDFPDF
Letter to the editor
MHRA alert about Nexplanon migration
  1. Kate Savage1,
  2. Kenneth Menon2
  1. 1 Ongar Health Centre, Fyfield Road, Ongar, Essex CM5 0AL, UK; katesavage@nhs.net
  2. 2 Ongar Health Centre, Fyfield Road, Ongar, Essex CM5 0AL, UK; kenmenon@aol.com
  1. Correspondence to Dr Kenneth Menon, Ongar Health Centre, Ongar, UK; kenmenon{at}aol.com

https://doi.org/10.1136/jfprhc-2017-101881

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Following the Medicines and Healthcare products Regulatory Agency (MHRA) alert about migration of Nexplanon® on 15 June 2016,1 we audited the quality of insertion of the implant in patients at our surgery.

    We wrote to a total of 127 patients asking them whether they could feel the shaft and/or the ends of the implant in …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.